SCHEMBL6601005

SCHEMBL6601005

FC(C(F)(F)F)C(F)(F)Oc1ccc(Br)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
TSHR P16473 1/20 0.59
HSD17B10 Q99714 1/20 0.59
TRPV1 Q8NER1 2/20 0.41
RECQL P46063 1/20 0.34
MAPT P10636 3/20 0.33
LDHA P00338 1/20 0.33
CHRNA7 P36544 1/20 0.33
CYP2A6 P11509 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
HPGD P15428 2/20 0.32
KMT2A Q03164 2/20 0.32
EPHX2 P34913 1/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11679555 0.89 ALDH1A1 (0.69) ALDH1A1TSHRHSD17B10TRPV1RECQL
SCHEMBL3945050 0.85 TRPV1 (0.51) ALDH1A1TSHRHSD17B10TRPV1MAPT
SCHEMBL14241924 0.82 ALDH1A1 (0.40) ALDH1A1TSHRHSD17B10TRPV1MAPT
SCHEMBL1361753 0.80 ALDH1A1 (0.59) ALDH1A1TSHRHSD17B10TRPV1RECQL
SCHEMBL6604311 0.79 ALDH1A1 (0.54) ALDH1A1TSHRHSD17B10TRPV1RECQL
SCHEMBL706601 0.79 TSHR (0.62) ALDH1A1TSHRHSD17B10RECQLMAPT
SCHEMBL14227130 0.78 ALDH1A1 (0.38) ALDH1A1TSHRHSD17B10TRPV1MAPT
SCHEMBL7988352 0.77 ALDH1A1 (0.60) ALDH1A1TSHRHSD17B10TRPV1MAPT
SCHEMBL15031221 0.77 ALDH1A1 (0.56) ALDH1A1TSHRHSD17B10TRPV1RECQL
SCHEMBL29309503 0.77 ALDH1A1 (0.56) ALDH1A1TSHRHSD17B10TRPV1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040152903-A1 6-chloro-3-pyridylmethylpropylamine derivatives, preparation process thereof and bactericides KUREHA CORPORATION (JP) 2004-08-05 US disclosed
EP-1375483-A1 6-CHLORO-3-PYRIDYLMETHYLPROPYLAMINE DERIVATIVES, PREPARATION PROCESS THEREOF AND BACTERICIDES KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2004-01-02 EP disclosed
EP-0640578-B2 Novel liquid crystalline compound having a 1,1,2,3,3,3,-hexafluoropropyl group and liquid crystal composition CHISSO CORP (JP) 2001-06-27 EP disclosed
EP-0718264-B1 A liquid crystalline compound containing fluorine atom substituted alkyl group(s) and a liquid crystal composition CHISSO CORP (JP) 1999-11-17 EP disclosed
US-5702641-A ELECTRICAL AND CHEMICAL STABILITY CHISSO CORPORATION (JP) 1997-12-30 US disclosed
EP-0640578-B1 Novel liquid crystalline compound having a 1,1,2,3,3,3,-hexafluoropropyl group and liquid crystal composition CHISSO CORP (JP) 1997-11-05 EP disclosed
CN-1130670-A Liquid crystalline compound containing fluorine atom substituted alkyl group(s) and a liquid crystal composition CHISSO CORP (JP) 1996-09-11 CN disclosed
EP-0718264-A1 A liquid crystalline compound containing fluorine atom substituted alkyl group(s) and a liquid crystal composition Chisso Corporation (JP) 1996-06-26 EP disclosed
EP-0640578-A1 Novel liquid crystalline compound having a 1,1,2,3,3,3,-hexafluoropropyl group and liquid crystal composition Chisso Corporation (JP) 1995-03-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152903-A1 6-chloro-3-pyridylmethylpropylamine derivatives, preparation process thereof and bactericides PGLS, TLR6, UROD ALDH1A1 2464/4885TSHR 3142/4885HSD17B10 4601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.